Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven in Post-operative Bleeding Following Cardiac Surgery
NCT00154427Phase 2Terminated
- Sponsor
- Novo Nordisk
- Start
- Aug 2004
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
Phase 2, randomised, double-blind trial of coagulation factor VIIa in postoperative hemorrhage (3 arms), sponsored by Novo Nordisk. Primary endpoint: Incidence of critical, serious adverse events at 30 days. Started Aug 2004; status: terminated.
02
Drugs
coagulation factor VIIa
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT00154427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154427.